Skip to main content

Hwang, Kihwan

Seoul National University · Medicine

About the Lab

Professor Hwang Kihwan's research lab specializes in neuro-oncology and cerebrovascular diseases, with a primary focus on improving treatment outcomes for glioblastoma and acute ischemic stroke. The lab investigates novel therapeutic strategies, including PARP and alkylating agent combinations, adjuvant chemotherapy, and endovascular interventions in elderly stroke patients. It also explores the role of antiepileptic drugs like levetiracetam as radiosensitizers and evaluates prognostic factors in brain tumors such as pilocytic astrocytomas. The research emphasizes translational approaches, combining clinical trials with advanced imaging and patient outcome analysis to optimize individualized neurosurgical and oncological care.

glioblastomaendovascular treatmenttemozolomideacute ischemic strokebrain tumors

Research Overview

Papers
117
Total Citations
552
Papers (5y)
71
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
71total
2022
2023
2024
2025
2026
Citations per year (5y)
150total
20222023202420252026

Selected Papers

15
1
Article|31 citations·2018
PD-1/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population
Kihwan Hwang, Eun Jung Koh, Eun Jin Choi, Tae Hee Kang, Jung Ho Han, Gheeyoung Choe, Sung‐Hye Park, Jennifer H. Yearley, Lakshmanan Annamalai, Wendy M. Blumenschein, Manjiri Sathe, Terri McClanahan
SJR Q1Journal of Neuro-Oncology
Molecular BiologyBiochemistry, Genetics and Molecular Biology
2
Article|22 citations·2021
The Combination PARP Inhibitor Olaparib With Temozolomide in an Experimental Glioblastoma Model
Kihwan Hwang, Jin‐Han Lee, Sang Ho Kim, Kyeong-O Go, So Young Ji, Jung Ho Han, Chae‐Yong Kim
SJR Q2In VivoOA

The combination of the PARP inhibitor olaparib with temozolomide could be promising candidates for combination therapy of glioblastoma regardless of the MGMT promoter methylation status.

OncologyMedicine
3
Article|20 citations·2019
Risk factors for preoperative and late postoperative seizures in primary supratentorial meningiomas
Kihwan Hwang, Jin‐Deok Joo, Young‐Hoon Kim, Jung Ho Han, Chang Wan Oh, Chang‐Ho Yun, Seong-Ho Park, Chae‐Yong Kim
SJR Q2Clinical Neurology and Neurosurgery
EpidemiologyMedicine
4
Article|19 citations·2021
Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open‐label phase 2 study
Kihwan Hwang, Junhyung Kim, Seok‐Gu Kang, Tae‐Young Jung, Jeong Hoon Kim, Se‐Hyuk Kim, Shin‐Hyuk Kang, Yong‐Kil Hong, Tae Min Kim, Yu Jung Kim, Byung Se Choi, Jong Hee Chang
SJR Q1Cancer MedicineOA

BACKGROUND: An open-label single-arm phase 2 study was conducted to evaluate the role of levetiracetam as a sensitizer of concurrent chemoradiotherapy (CCRT) for patients with newly diagnosed glioblastoma. This study aimed to determine the survival benefit of levetiracetam in conjunction with the standard treatment for glioblastoma. METHODS: Major eligibility requirements included histologically proven glioblastoma in the supratentorial region, patients 18 years or older, and Eastern Cooperative

GeneticsMedicine
5
Article|19 citations·2014
Endovascular Embolization of a Ruptured Distal Lenticulostriate Artery Aneurysm in Patients with Moyamoya Disease
Kihwan Hwang, Gyojun Hwang, O-Ki Kwon
SJR Q2Journal of Korean Neurosurgical SocietyOA

A ruptured distal lenticulostriate artery (LSA) aneurysm is detected occasionally in moyamoya disease (MMD) patients presented with intracerebral hemorrhage. If the aneurysm is detected in hemorrhage site on angiographic evaluation, its obliteration could be considered, because it rebleeds frequently, and is associated with poorer outcome and mortality in MMD related hemorrhage. In this case report, the authors present two MMD cases with ruptured distal LSA aneurysm treated by endovascular embol

RheumatologyMedicine
6
Article|16 citations·2015
Endovascular Treatment for Acute Ischemic Stroke Patients over 80 Years of Age
Kihwan Hwang, Gyojun Hwang, O-Ki Kwon, Chang Hyeun Kim, Seung Pil Ban, Moon‐Ku Han, Hee‐Joon Bae, Beom Joon Kim, Jae Seung Bang, Chang Wan Oh, Boram Lee, Eun-A Jeong
SJR Q3Journal of Cerebrovascular and Endovascular NeurosurgeryOA

OBJECTIVE: We evaluated the effect of endovascular treatment (EVT) for acute ischemic stroke in patients over 80 years of age. MATERIALS AND METHODS: The records of 156 acute stroke patients aged over 80 years who were considered as candidates for EVT were analyzed. Fifty-six patients (35.9%, EVT group) underwent EVT and 100 patients (64.1%, non-EVT group) did not. Outcomes, in terms of functional outcomes and rates of symptomatic hemorrhage, in-hospital morbidity and mortality, were compared be

EpidemiologyMedicine
7
Article|15 citations·2019
Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)
Kihwan Hwang, Tae Min Kim, Chul‐Kee Park, Jong Hee Chang, Tae‐Young Jung, Jin Hee Kim, Do‐Hyun Nam, Se-Hyuk Kim, Heon Yoo, Yong-Kil Hong, Eun Young Kim, Dong-Eun Lee
SJR Q1Cancer Research and TreatmentOA

PURPOSE: We investigated the efficacy of temozolomide during and after radiotherapy in Korean adults with anaplastic gliomas without 1p/19q co-deletion. MATERIALS AND METHODS: This was a randomized, open-label, phase 2 study and notably the first multicenter trial for Korean grade III glioma patients. Eligible patients were aged 18 years or older and had newly diagnosed non-co-deleted anaplastic glioma with an Eastern Cooperative Oncology Group performance status of 0-2. Patients were randomized

GeneticsMedicine
8
Article|13 citations·2018
Seizures After Stereotactic Radiosurgery for Benign Supratentorial Meningiomas: An Uncontrollable Type of Seizure?
Kihwan Hwang, Dong Gyu Kim, Sun Ha Paek, Chae‐Yong Kim, Chang‐Ho Yun, Chang Wan Oh, R Juh, Jung Ho Han
SJR Q2World Neurosurgery
EpidemiologyMedicine
9
Article|12 citations·2019
Growth Pattern and Prognostic Factors of Untreated Nonfunctioning Pituitary Adenomas
Kihwan Hwang, Tae-Hun Kwon, Jay J. Park, Jin-Deok Joo, Jung Ho Han, Chang Wan Oh, Chae‐Yong Kim
SJR Q2Journal of Korean Neurosurgical SocietyOA

The initial tumor size of PAs was independently associated with the tumor growth. Six patients (11%) of conservatively managed PAs were likely to be treated eventually. PAs of last follow-up longest diameter over 21.75 mm were a significant prognostic factor for treatment. Further studies with a large series are required to determine treatment strategy.

Endocrinology, Diabetes and MetabolismMedicine
10
Article|9 citations·2021
Tissue Engineering and Regenerative Medicine Cranioplasty Using Polycaprolactone-Tricalcium Phosphate: Management and Treatment Outcomes
Kihwan Hwang, Jay B Villavicencio, Anna May P Agdamag
SJR Q3Neurosurgery PracticeOA

ABSTRACT BACKGROUND Cranioplasty is a procedure commonly performed as the next step in management for patients with decompressive craniectomy. It is commonly associated with complications that might result in implant failure and reoperation. Tissue engineering and regenerative medicine (TERM) involve the development of biological substitutes that restore tissue function and regrow and replace damaged tissues. TERM is a potential solution that might allow for improved long-term outcomes in cranio

Biomedical EngineeringEngineering
11
Article|8 citations·2020
The outcomes of conservatively observed asymptomatic nonfunctioning pituitary adenomas with optic nerve compression
Kihwan Hwang, Yong Hwy Kim, Jung Hee Kim, Jung Hyun Lee, Hee Kyung Yang, Jeong‐Min Hwang, Chae‐Yong Kim, Jung Ho Han
SJR Q1Journal of neurosurgeryOA

OBJECTIVE: The authors investigated the natural history of asymptomatic nonfunctioning pituitary adenomas (NFPAs) with optic nerve compression. METHODS: This study retrospectively analyzed the natural history of asymptomatic NFPAs with documented optic nerve compression on MRI diagnosed between 2000 and 2016 from 2 institutions. The patients were followed up with regular endocrinological, ophthalmological, and radiological evaluations, and the endpoint was new endocrinopathy or neurological defi

Endocrinology, Diabetes and MetabolismMedicine
12
Article|6 citations·2022
Fully Automated Segmentation Models of Supratentorial Meningiomas Assisted by Inclusion of Normal Brain Images
Kihwan Hwang, Juntae Park, Youngjae Kwon, Se Jin Cho, Byung Se Choi, Jiwon Kim, Eunchong Kim, Jongha Jang, Kwang‐Sung Ahn, Sangsoo Kim, Chae‐Yong Kim
SJR Q1Journal of ImagingOA

To train an automatic brain tumor segmentation model, a large amount of data is required. In this paper, we proposed a strategy to overcome the limited amount of clinically collected magnetic resonance image (MRI) data regarding meningiomas by pre-training a model using a larger public dataset of MRIs of gliomas and augmenting our meningioma training set with normal brain MRIs. Pre-operative MRIs of 91 meningioma patients (171 MRIs) and 10 non-meningioma patients (normal brains) were collected b

EpidemiologyMedicine
13
Article|5 citations·2018
Secondary glioblastoma after treatment of intracranial germinoma - would radiation-only therapy still be safe? Case report
Kihwan Hwang, Kyu Sang Lee, Gheeyoung Choe, Byung-Gyu Cho, Chae‐Yong Kim
SJR Q2BMC CancerOA

BACK GROUND: Intracranial germinomas are one of the most radiosensitive tumors and are curable by radiotherapy (RT) alone. RT-only therapy without chemotherapy is effective. But, as patients with germinoma can expect long-term survival, the adverse effects of RT and late sequelae in survivors are of most concern. So, recently, standard treatment protocol of combination with chemotherapy and reduced dose of RT could be widely acceptable. CASE PRESENTATION: We report a patient with germinoma who d

GeneticsMedicine
14
Review|5 citations·2020
Cerebellar Pleomorphic Xanthoastrocytoma with BRAF V600E Mutation
Sang Ho Kim, Kihwan Hwang, Kyu Sang Lee, Gheeyoung Choe, Chae‐Yong Kim
SJR Q2World Neurosurgery
GeneticsMedicine
15
Article|4 citations·2015
CT Fluoroscopy-guided Aspiration of Intracerebral Hematomas: Technique and Outcomes
Kihwan Hwang, Gyojun Hwang, O-Ki Kwon, Jae Seung Bang, Chang Wan Oh
SJR Q3Journal of Cerebrovascular and Endovascular NeurosurgeryOA

OBJECTIVE: The authors evaluated the feasibility and targeting accuracy of CT fluoroscopy (CTF)-guided catheter placement and aspiration of intracerebral hematoma (ICH)s. MATERIALS AND METHODS: Nine patients (mean age, 63.3 ± 15.3 years) were treated by CTF-guided hematoma aspiration under local anesthesia. The targeting errors in the lesion center, volume of the aspirated hematoma, accuracy of the final catheter position, procedure time, and clinical outcomes were evaluated. RESULTS: All cathet

NeurologyMedicine

Research Areas

GeneticsEpidemiologySurgeryBiomedical EngineeringMolecular BiologyEndocrinology, Diabetes and Metabolism

Dive deeper into Hwang, Kihwan's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.